C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/42 (2006.01) A61K 31/505 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2395049
The invention provides the compounds of formula (I) and pharmaceutically acceptable derivatives thereof, in which: R1 and R2 are independently selected from H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl or C4- 12bridged cycloalkane; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.
L'invention concerne des composés représentés par la formule (I) et leurs dérivés pharmaceutiquement acceptables. Dans ladite formule, R?1¿ et R?2¿ sont indépendamment choisis parmi H, C¿1-6?alkyle, C¿2-6?alcényle, C¿3-6?alcynyle, C¿3-10?cycloalkylC¿0-6?alkyle ou C¿4-12?cycloalcane ponté ; et R?3¿ représente C¿1-6?alkyle ou NH¿2?. Les composés représentés par la formule (I), qui sont de puissants inhibiteurs sélectifs de COX-2, sont utilisés dans le traitement de la douleur, de la fièvre et de l'inflammation associées à divers états pathologiques et maladies.
Green Richard Howard
Hartley Charles David
Naylor Alan
Payne Jeremy John
Pegg Neil Anthony
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Pyrimidine derivatives as selective inhibitors of cox-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives as selective inhibitors of cox-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as selective inhibitors of cox-2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1893553